Experts in Residence

The “Experts in Residence” scheme is managed by the Translational Research Office. It aims to give Oxford's research community access to world-leading expertise and advice across multiple industry sectors. Scientists can arrange meetings with our experts to discuss their ideas and projects with no strings attached. We expect that this advice and support will help scientists develop the translational strategy for their projects/technologies.

View a brochure detailing the structure of the program, key stakeholders, testimonials, and a directory for researchers to learn more about the experts.

Our Experts

Book a meeting with one of our Experts in Residence

 Product Design in Biomedical Engineering 

 Mr Patrick Hall, Managing Director, Designing Science Ltd

 Dr Kerry Briggs, VP Design and Development Europe, Kinneir Dufort

Dr James Holmes, Head of Electronics, Kinneir Dufort

  Dr Rouzet Agaiby, Director, EG technology 

Dr Giles Sanders, Head of In Vitro Diagnostics, TTP

 Dr Stuart Lowe, Head - Biotechnology, Cell and Gene Therapy, TTP 

Imaging technologies 

Dr Jan Wolber, Product Leader - Digital, GE Healthcare Pharmaceutical Diagnostics  

 Drug Discovery and development 

Dr Rachel Grimley, Senior Vice President, Drug discovery, Cancer Research UK 

Professor Simon Hollingsworth, VP, Global Franchise Head, AstraZeneca

Dr Rachel Hemsley, Business Development Director, Sygnature Discovery

Dr Colin T Dourish, Director and Co-Owner of Blue Day Healthcare 

Dr Anthony Brown, VP Business Development & Alliance Management at Carrick                                                                                       Therapeutics, CEO & Founder Drug Discovery Limited

Dr Holger Hess-Stumpp, Head of Strategic Alliances and Business Development in DKFZ Innovation Management

Dr David Reynolds, Founder of AstronauTx and CEO at LoQus23

Dr Tom Oakley, Founder and Principal Consultant - Somerville Development Partners

Dr Yatish Lad, Founder and Principal Consultant, Yatish Lad Consulting

Dr Andy Pearce, Global Project Leader, Cardiovascular, Renal and Metabolic                                                                                                                                                   Diseases, AstraZeneca

Digital Health 

Dr Steve Gardner, Co-founder and CEO, PrecisionLife

Dr Veronique Bouchet, Chief Medical Officer, PrecisionLife

 Mr Paul O'Donohoe, Senior Director, eCOA Product and Science at Medidata Solutions

Dr Bobby Kaura, Seed Investment, EMEA Outreach & International Development, Illumina Accelerator

Medical Technologies -  Regulatory and Market Access 

Dr Toni Day, Global Director of Quality & Regulatory Affairs, Organox

 Mr Richard Hall, Director, QMS Consultancy

Dr Ben Wensley-Stock, Chief Executive Officer, MPS Medical-Product-Service UK Ltd

Dr Steven Haken, Managing Director at Odelle Technology

Ms Amy Peters, Head of Government Affairs and Policy for AbbVie UK

Diagnostics

 Prof Rosanna Peeling, Founding Director of the International Diagnostic Centre (IDC) Network

Clinical Research

Dr Steve McConchie, Operations & Partnership Director for Lean Life Science 

Dr Matthew Reaney, Head of Global Science & Analytics, Patient Centered Solutions,                                                                                                                                                                              IQVIA

 Professor Jeremy Kirk, R&D Director Birmingham Women and Children’s Hospital and                                                                                     former CD NIHR Clinical Research Network for West Midlands

Innovation and commercial opportunities

Mr Paul Cox, General Manager UK, Ireland and Nordics, Apellis Pharmaceuticals

Dr Nicholas Duggan, Founder at Zuas; Director at Proteus Materials

 Dr Joanne Hackett, Vice President and Head of Health System Services at IQVIA 

Dr Laura Ferguson, Director, Platform Technologies Search and Evaluation, at AstraZeneca

Dr Karen Wai, Chief Executive Officer, DentX